CD44 and lip and oral cavity carcinoma: Su et al. (2019) investigated the use of anti-CD44 antibody-conjugated superparamagnetic iron oxide nanoparticles to target CD44, a well-characterized oral carcinoma biomarker that facilitates cancer cell immune evasion.